Zydus and CSIR-CDRI launch collaborative research for new CKD-induced osteoporosis treatment
Zydus Lifesciences Ltd and CSIR-Central Drug Research Institute (CDRI) have joined forces to develop an innovative drug targeting osteoporosis induced by chronic kidney disease (CKD). Chronic kidney disease, affecting over 10% of the global population, has long posed severe health challenges, leading to complications such as bone mineral disruptions and an increased risk of fractures. […]